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Abstract
Background: Recent studies have shown that autophagy was associated with the development of osteoarthritis
(OA), the purpose of this research was to determine the exact role of autophagy in OA and investigate effective
therapeutic drugs to inhibit the pathological progression of OA.
Methods: In this study, a cellular OA model was generated by stimulating SW1353 cells with IL-1β and a rabbit OA
model was established by intra-articular injection of collagenase, followed by treatment with Torin 1 or 3-
Methyladenine (3-MA). The mRNA expression levels of VEGF, MMP-13 and TIMP-1 were determined by quantitative
real-time PCR. The caitilage degeneration was examined by histological evaluation, chondrocytes degeneration and
autophagosomes were observed by transmission electron microscopy. Expression levels of Beclin-1 and LC3 were
evaluated by western blotting and immunofluorescence.
Results: The degeneration of SW 1353 cells, cartilage and chondrocytes was related to the loss of autophagy in
experimental OA. 3-MA increased the severity of degeneration of cells and cartilage by autophagy inhibition, while
Torin 1 reduced that by autophagy activation.
Conclusions: The loss of autophagy is linked with the experimental OA and autophagy may play a protective role
in the pathogenesis of OA. Treatment of Torin 1 can inhibit the degenerative changes of experimental OA by
activating autophagy and it may be a useful therapeutic drug for OA.
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Background
Autophagy is a cellular self-protection mechanism [1, 2] by
removing damaged organelles and intracellular unfolded
proteins [3]. It has been suggested to remain cellular
homeostasis under stress conditions including xenobiotics,
oxidants, infection and hypoxia [4]. However, autophagy
has dual role in cell mechanism and homeostasis with both
beneficial and pathogenic effects [5]. It may protect against
numerous diseases including neurodegeneration, myopathy,
liver disease and diabetes [6], while excessive autophagy
can cause autophagic cell death [7, 8], and recent reports
have shown that suppression of autophagy may lead to tis-
sue degeneration [9, 10].
There are three major subtypes of autophagy: macroau-
tophagy (normally called autophagy) [11], microautophagy
[12] and chaperone-mediated autophagy [13]. Mitophagy
plays an important role in the clearance of dysfunctioned
mitochondria [14]. Autophagy mentioned in this paper is
macroautophagy.
The most important characteristic of autophagy is the
formation of autophagosomes [15], they fuse with lyso-
somes to form autolysosomes, and then the contents in
autolysosomes will be degraded by lysosomal enzyme [16].
In this process, the expression levels of Beclin-1 and the
LC3-II/LC3-I ratio are increased [17, 18]. Beclin-1 inter-
acts with a multi-protein complex containing Vps34, a
class III phosphatidylinositol-3 kinase (PI3KC3) [19] to
initiate the formation of autophagosome. LC3 plays an* Correspondence:
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important role in the autophagosome elongation and mat-
uration [20].
Osteoarthritis (OA), also known as hypertrophic arth-
ritis, is a degenerative joint disease and has become a
prevalent clinical disorder in the elder [21]. Research has
shown that many growth factors, cytokines and enzymes
such as Interleukin (IL)-1β [22], metalloproteinases
(MMPs) [23], inhibitors of metalloproteinase (TIMP)-1
[24] and collagenase [25] are closely related to the patho-
genesis of OA. In addition, angiogenesis has been sug-
gested to play important role in degeneration of articular
cartilage after OA, and the level of vascular endothelial
growth factor (VEGF) in OA cartilage is increased [26].
Because of these findings, IL-1β and collagenase are often
applied to produce OA model for in-vitro and in-vivo
studies [27, 28], while VEGF, MMPs and TIMP-1 are used
to detect the degree of chondrocytes degeneration.
OA is mainly characterized by the death of chondrocytes
and cartilage degeneration [29]. Accumulating evidences
suggest that autophagy is closely related to the pathogenesis
of OA. Some studies have shown that autophagy may keep
chondrocytes survival in articular cartilage, and the expres-
sion levels of Beclin-1 and LC3-II in knee OA patients or
models are increased [30, 31], while results obtained by
some other studies are completely opposite [32, 33]. Mean-
while, there are currently no available effective drugs and
measures for the prevention and treatment for OA in the
clinical.
In this study, a cellular OA model was generated by
stimulating SW1353 cells with IL-1β and a rabbit OA
model was established by intra-articular injection of col-
lagenase, followed by treatment with Torin 1 (a chemical
autophagy inducer) or 3-Methyladenine (3-MA, a chem-
ical autophagy inhibitor). The mRNA expression levels
of VEGF, MMP-13 and TIMP-1 were determined by
quantitative real-time PCR. The caitilage degeneration
was examined by histological evaluation, chondrocytes
degeneration and autophagosomes were observed by
transmission electron microscopy. Expression levels of
Beclin-1 and LC3 were evaluated by western blotting
and immunofluorescence. The aim of this study was to
determine the role of autophagy in OA and investigate
the possible therapeutic drugs for OA.
Methods
Cellular OA model induced by IL-1β
Human chondrosarcoma SW 1353 cells were purchased
from Institute of Life Science Cell Culture Center
(Shanghai, China) and stimulated with IL-1β (10 ng/mL,
Peprotech, US) to produce a cellular OA model. After
stimulation for 1 h, the cells were treated with Torin 1
(250 nM, Selleck, US) or 3-MA (5 mM, Sigma, US) and
incubated at 37 °C for 48 h. The cells without any treat-
ment were used as controls.
Quantitative real-time polymerase chain reaction (qRT-PCR)
Total RNA was extracted using the Trizol reagent (Invi-
trogen, US). The primers for VEGF, MMP-13, TIMP-1
and β-actin were: VEGF: forward, 5′-CCCACGTCAGA-
GAGCAACA-3′, reverse, 5′-TCACATCTGCTGTGC
TGTAGG-3′; MMP-13: forward, 5′-CGACTTCTACC-
CATTTGA-3′, reverse, 5′-TAGCCTTTGGAACTACT
TGTC-3′; TIMP-1: forward, 5′-AGATAGCCTGAAT
CCTGCC-3′, reverse, 5′-CTGGGTGGTAACTCTTT
ATTTC-3′; β-actin, forward, 5′-TCGACAACGGC
TCCGGCAT-3′, reverse, 5′-AAGGTGTGGTGCCA-
GATTTTC-3′. All genes were analyzed using a 7500
Real Time PCR System (ABI, USA). Each sample was
analyzed for 3 times and the mean values were calcu-
lated [34], and the test was repeated 3 times. The ex-
pression of target genes, relative to β-actin, was
calculated using the 2-ΔΔCT method.
Immunofluorescence
Cells were seeded on a glass coverslip into a 6-well plate.
After treatment, a DAPI immunofluorescence staining
protocol was carried out. The rabbit anti-LC3 primary
antibody was obtained from Cell Signaling Technology,
the donkey anti-rabbit secondary antibody was obtained
from Alexa Fluor. Each sample had 3 replicate wells and
the test was repeated 3 times. The slides were examined
under a confocal microscopy (Olympus, Japan).
Rabbit OA model
Twenty healthy male New Zealand white rabbits at
3 months old (weighing 2.4–2.6 kg) were provided by
the Animal Center of Capital Medical University
(Beijing, China). All animal experiments were approved
by the Institutional Animal Care and Use Committee.
Rabbits were randomly assigned to three experimental
groups and one control group. All animals were sacri-
ficed at the end of 8 weeks after the initiation of experi-
ment. The bilateral knee joints of animals of the first
experimental group received intra-articularly injection
with 0.5 ml saline containing 1.0 mg collagenase (type II,
Sigma, US) to establish a rabbit OA model, the second ex-
perimental group received injection of 1.0 mg collagenase
combined with 250 nM Torin 1, and the third experimen-
tal group received injection of 1.0 mg collagenase com-
bined with 5 mM 3-MA. The injection was performed
twice at day 1 and day 4 as reported [28]. Rabbits of the
control group received twice injections of 0.5 ml normal
saline. Penicillin and streptomycin were used to prevent
infection by gluteal muscle injection, and side effects such
as weight loss, diarrhea, anemia, proteinuria and allergy
were not observed in this study. Cartilage samples dis-
sected out from the knee joints of 5 rabbits in each group,
giving a total of 10 joints, were used for histological evalu-
ation, transmission electron microscope observation and
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western blotting, avoiding inclusion of both joints from 1
rabbit in each test.
Histological evaluation
The lateral femoral condyles of each group were separated
and prepared (n = 10). After decalcification and dehydra-
tion, the samples were paraffin-embedded and cut into
5 μm microsections in the sagittal plane, then stained with
hemotoxylin and eosin (H&E). Grading of staining was
evaluated by blinded observers using scoring according to
the Mankin scoring system (Table 1) [35].
Transmission electron microscopy
Cartilage from medial femoral condyles was fixed with
2.5 % glutaraldehyde in PBS and rinsed with PBS. After
decalcification, the samples were further fixed with 1 %
OsO4, rinsed with PBS, dehydrated by a series of etha-
nol, and incubated in isoamyl acetate. Finally, the sam-
ples were embedded in gold-palladium, cut into
ultrathin sections, and observed under a transmission
electron microscopy (TEM, Hitachi, Japan).
Western blotting
Cartilage from tibial plateau was separated and prepared,
each cartilage from 3 out of 10 tibial plateaus was pooled
as one sample (n = 3), and the total protein of cells and
cartilage in each group was extracted. The protein con-
centrations were measured using a bicinchoninic acid re-
agent assay (Thermo, US). Equal amount of proteins
(50 μg) were separated by Tris-glycine gels (Sigma, US)
and transferred onto nitrocellulose membranes (Millipore,
US). The membranes were blocked with 5 % nonfat milk
and incubated with antibodies specific for Beclin-1, LC3
(Cell signaling Technology, US) and β-actin (Santa Cruz,
US). Then the nitrocellulose sheet was incubated with a
horse-radish peroxidase (HRP)-conjugated secondary anti-
body (Zhongshan Golden Bridge Biotechnology, Beijing,
China) and subjected to signal development by using en-
hanced chemiluminescence (ECL) substrate (Thermo,
US). Each sample was analyzed three times and the mean
gray values of immunoblot band were calculated [34].
Statistical analysis
Statistical analysis was performed with one-way ANOVA
using SPSS statistical software 19.0 (Chicago, IL, USA).
The data was expressed as the mean ± standard deviation
(SD). A difference of P value less than 0.05 was considered
to be statistically significant.
Results
VEGF, MMP-13 and TIMP-1 expression
The mRNA expression level of VEGF (Additional file 1)
and MMP-13 (Aditional file 2) in IL-1β-induced SW1353
cells were significantly increased compared with that in
normal cells (Both P < 0.001) (Fig. 1a and b), and the ex-
pression level of TIMP-1 (Additional file 3) was signifi-
cantly decreased (P < 0.001) (Fig. 1c). In addition, the
increase in VEGF and MMP-13 expression, and decrease in
TIMP-1 expression were significantly inhibited by Torin 1
(P = 0.002, <0.001 and = 0.025), while the effects of 3-MA
were exactly opposite (P < 0.001, <0.001 and = 0.023).
Beclin-1 and LC3 expression in SW1353 cells
Based on above results, some autophagy-related proteins
were detected (Fig. 2a). The protein expression of Beclin-1
(Additional file 4) and the LC3-II/LC3-I ratio (Additional
file 5) were decreased in IL-1β-induced SW1353 cells
compared with that in normal cells (Both P < 0.001). Both
the expression levels of Beclin-1 and the LC3-II/LC3-I ra-
tio were much higher in cells treated with IL-1β in com-
bination with Torin 1 than in cells only treated with IL-1β
(P = 0.001 and 0.019), while they were lower in cells
treated with IL-1β in combination with 3-MA (P = 0.026
and 0.659) (Fig. 2b, c). We further evaluated LC3 protein
expression by immunofluorescence and found that LC3
was expressed in normal cells and decreased in IL-1β
treated SW1353 cells. Moreover, the expression of LC3
was higher in cells treated with IL-1β in combination with
Torin 1, and lower in cells treated with IL-1β in combin-
ation with 3-MA than in cells only treated with IL-1β
(Fig. 2d). The results obtained by immunofluorescence
were consistent with western blotting.
Histological changes
In the control group, the cartilage was not degenerated and
its surface was smooth. In the collagenase-injected group,
the loss of cartilage had extended to the radial zone, cell
cloning of chondrocytes and reduced stain ability were ap-
parent in the radial zone. In the Torin 1-treated group, the
loss of cartilage had only extended to the transitional zone,
disappearance of cells in the transitional zone, cell cloning
in the radial zone and reduced stain ability were observed.
But in the 3-MA-treated group, much more clefts and loss
of cartilage and seriously reduced stain ability were seen in
the radial zone (Fig. 3a). The mankin scores (Additional file
6) of the collagenase-injected group were higher than those
of the control group (P < 0.001), and the scores were lower
in the Torin 1-treated group but higher in the 3-MA-
treated group when compared with collagenase-injected
group (Both P < 0.001) (Fig. 3b and Table 2).
Table 1 Mankin scoring system
Articular cartilage
(1) Structure (7 grades)
(2) Cell (4 grades)
(3) Safranin-O staining (5 grades)
(4) Tidemark (2 grades)
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TEM observation
Chondrocytes degeneration and autophagosomes were ex-
amined by TEM (Fig. 4). In the control group, chondro-
cytes were located in the lacunae and contained round
nuclei with discontinuous nuclear membranes, some vesi-
cles were observed in the cytoplasm. In the collagenase-
injected group, typical condensed chondrocytes with sev-
eral autophagic vacuoles were observed, the number of
autophagosomes in collagenase treated chondrocytes was
less than the controls, and the nuclei of chondrocytes
were disappeared. In the Torin 1-treated group, autophagy
became more pronounced and much more autophago-
somes were observed in chondrocytes. Meanwhile, abun-
dant rough endoplasmic reticulum (RER) and a few other
organelles were found in the cytoplasm. Moreover, the
nuclei of chondrocytes were present, and condensed
Fig. 1 The mRNA expression of VEGF, MMP-13 and TIMP-1. a, b The mRNA expression levels of VEGF and MMP-13 in IL-1β-induced SW1353 cells
were significantly increased compared with that in normal cells. c The mRNA expression level of TIMP-1 was significantly decreased. The increase
in VEGF and MMP-13 expression, and decrease in TIMP-1 expression were significantly inhibited by Torin 1, while the effects of 3-MA were exactly
opposite. n = 3 for each group, and the test was repeated 3 times. *P < 0.05, **P < 0.01, ***P < 0.001
Fig. 2 The expression of Beclin-1 and LC3 in SW1353 cells. a The protein expression of Beclin-1 and LC3 evaluated by western blotting. b, c Quantitative
analysis showed that the protein expression of Beclin-1 and the LC3-II/LC3-I ratio were decreased in IL-1β-induced SW1353 cells compared with that in
normal cells. Both the expression levels of Beclin-1 and the LC3-II/LC3-I ratio were much higher in cells treated with IL-1β in combination with Torin 1 than
in cells only treated with IL-1β, while they were lower in cells treated with IL-1β in combination with 3-MA. n= 3 for each group. d The expression of LC3
evaluated by immunofluorescence. LC3 was expressed in normal cells and decreased in IL-1β treated SW1353 cells. Moreover, the expression of LC3 was
higher in cells treated with IL-1β in combination with Torin 1 and lower in cells treated with IL-1β in combination with 3-MA. n= 3 for each group, and
the test was repeated 3 times. *P< 0.05, **P< 0.01, ***P< 0.001
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chromatin produced a convoluted pattern. In the 3-MA-
treated group, the contents in chondrocytes had been sub-
stantially degraded. Disappeared nuclei, a number of cell
debris and a large autophagosome were observed.
Beclin-1 and LC3 expression in rabbit OA model
Western blotting analysis showed a significantly reduction
of Beclin-1 expression (Additional file 7) and the LC3-II/
LC3-I ratio (Additional file 8) in the collagenase-injected
group compared with the control group (P = 0.002 and
<0.001). Similarly, expression levels of Beclin-1 and the
Fig. 3 Histological changes in cartilage and Mankin scores. a In
the control group, the cartilage was not degenerated and its
surface was smooth. In the collagenase-injected group, the loss of
cartilage had extended to the radial zone, cell cloning of chondrocytes
and reduced stain ability were apparent in the radial zone. In the Torin
1-treated group, the loss of cartilage had only extended to the
transitional zone, disappearance of cells in the transitional zone, cell
cloning in the radial zone and reduced stain ability were observed. But
in the 3-MA-treated group, much more clefts and loss of cartilage and
seriously reduced stain ability were seen in the radial zone. b The
scores of the collagenase-injected group were higher than those of
the control group, and the scores were lower in the Torin 1-treated
group but higher in the 3-MA-treated group when compared with
collagenase-injected group. n = 10 for each group. ***P < 0.001
(Magnification, 100×)










Each data represents the mean ± SD (n = 10)
Fig. 4 TEM observation and autophagosomes evaluation. In the control
group, chondrocytes were located in the lacunae and contained round
nuclei with discontinuous nuclear membranes, some vesicles were
observed in the cytoplasm. In the collagenase-injected group, typical
condensed chondrocytes with several autophagic vacuoles were
observed, the number of autophagosomes in collagenase treated
chondrocytes was less than the controls, and the nuclei of chondrocytes
were disappeared. In the Torin 1-treated group, autophagy became
more pronounced and much more autophagosomes were observed in
chondrocytes. Meanwhile, abundant rough endoplasmic reticulum (RER)
and a few other organelles were found in the cytoplasm. Moreover, the
nuclei of chondrocytes were present, and condensed chromatin
produced a convoluted pattern. In the 3-MA-treated group, the contents
in chondrocytes had been substantially degraded. Disappeared nuclei, a
number of cell debris and a large autophagosome were observed.
(Bar, 1 μm)
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LC3-II/LC3-I ratio were much higher in the Torin 1-
treated group than in the collagenase-injected group
(P = 0.041 and 0.044), while they were lower in the 3-
MA-treated group (P = 0.225 and 0.178) (Fig. 5a, b
and c).
Discussion
OA has become one of the most common chronic joint
disease in clinical [36], the mechanism and effective
treatment to inhibit the pathological progression remain
to be the hot issues in the field of medical research. For
these reasons, many kinds of OA models have been pro-
duced using different materials and methods, such as
Hulth model [37], joint fixation [38] and intra-articular
injection of drugs [39, 40]. These models are thought to
be useful for the investigation of OA pathogenesis and
treatment.
Reports have shown that IL-1β and collagenase are in-
volved in the pathogenesis of OA [41, 42]. Based on
these studies, IL-1β is often used to build cellular OA
model [43, 44], and collagenase is used to establish OA
models by intra-articular injection [27, 28, 45]. In our
previous reports, we stimulated SW1353 cells with IL-
1β, and successfully induced degenerative changes in
SW1353 cells, such as loss of cell viability, increased
synthesis of MMPs, we determined that IL-1β could pro-
mote the occurrence of OA by activating the mitogen-
activated protein kinase (MAPK) pathway [46]. In the
present study, we still produce a cellular OA model by
IL-1β, and establish a rabbit OA model by intra-articular
injection of collagenase. We notice the significantly in-
creased expression levels of VEGF and MMP-13, and
the significantly decreased expression level of TIMP-1 in
SW1353 cells, accompanied by the degeneration of car-
tilage and chondrocytes in knee joints. These observa-
tions demonstrate degenerative changes in SW1353 cells
and knee joints separately induced by IL-1β and collage-
nase, but the physiologic differences between human
and model could still make differences between the re-
sults with the actual situation.
Autophagy plays an essential role in cellular metabolism
and homeostasis and can keep cell survival under stress
conditions [47]. In addition, autophagy has also been con-
sidered to take part in numerous diseases, including a var-
iety of orthopedic disorders, such as degradation of
Meckel's cartilage [48], intervertebral disc degeneration [49]
and OA [50, 51]. But recent results about the relationship
between autophagy and OA are sometimes contradictory
[30–33]. In this study, we detect the expression levels of
autophagy-related proteins, Beclin-1 and LC3, and we de-
termine the expression levels of them are significantly re-
duced both in IL-1β-induced cells and collagenase-induced
knee joints. Meanwhile, TEM observation show typical
condensed chondrocytes with several autophagic vacuoles,
Fig. 5 The Beclin-1 and LC3 expression in rabbit OA model. a The
protein expression of Beclin-1 and LC3 evaluated by western blotting.
b, c Quantitative analysis showed a significantly reduction of Beclin-1
expression and the LC3B-II/LC3B-I ratio in the collagenase-injected
group compared with the control group. Similarly, expression levels of
Beclin-1 and the LC3B-II/LC3B-I ratio were much higher in the Torin
1-treated group than in the collagenase-injected group, while they
were lower in the 3-MA-treated group. n = 3 for each group. *P < 0.05,
**P < 0.01, ***P < 0.001
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and the collagenase treated chondrocytes have less autop-
hagosomes than the controls. These results demonstrate
that the loss of autophagy is linked with the experimental
OA.
To determine the exact role of autophagy in OA and
investigate effective therapeutic drugs to inhibit the
pathological progression of OA, we add the treatment of
Torin 1 and 3-MA in celluar OA model and rabbit OA
model. We notice that the expression levels of Beclin-1
and LC3 are enhanced by Torin 1, the autophagy
become more pronounced and much more autophago-
somes are observed in chondrocytes of cartilage, and the
degenerative changes in cells and knee joints are inhib-
ited, while treatment of 3-MA leads to completely op-
posite results. Thus the present observations indicate
that autophagy may play a protective role in the patho-
genesis of OA. What’s more, treatment of Torin 1 can
inhibit the degenerative changes of experimental OA by
activating autophagy and it may be a useful therapeutic
drug for OA.
Conclusions
In summary, our results demonstrated that the degener-
ation of SW 1353 cells, cartilage and chondrocytes was
related to the loss of autophagy in experimental OA,
and 3-MA increased the severity of degeneration of cells
and cartilage by autophagy inhibition, while Torin 1 re-
duced that by autophagy activation. These observations
indicate that the loss of autophagy is linked with the ex-
perimental OA and autophagy may play a protective role
in the pathogenesis of OA. Furthermore, Treatment of
Torin 1 can inhibit the degenerative changes of experi-
mental OA by activating autophagy and it may be a use-
ful therapeutic drug for OA.
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